Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1365-1374

  Qin, Lihui ^a   Ding, Yaozhong ^a   Pahud, Dominique R ^a   Robson, Nicole D ^a   Shaked, Abraham ^b   Bromberg, Jonathan S ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOKINE; INTERLEUKIN 10; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ALLOGRAFT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE TRANSFER; GRAFT SURVIVAL; HEART GRAFT; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PROMOTER REGION; RAT; SIMIAN VIRUS 40;

ADENOVIRIDAE; ANIMALIA; MURINAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0030764114     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1365     Document Type: Article

References (49)

1. ALTEVOGT, P., KOHL, U., VON, H.P., LANG, E., and SCHIRR-MACHER, V. (1989). Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: Study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein. Eur. J. Immunol. 19, 341-346.
2. BRAMSON, J.L., GRAHAM, F.L., and GAULDIE, J. (1995). The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr. Opin. Biotechnol. 6, 590-595.
3. CASSATELLA, M.A., MEDA, L., BONORA, S., CESKA, M., and CONSTANTIN, G. (1993). Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178, 2207-2211.
4. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
5. H2 suppressor cells and receptor blockade. J. Immunol. 152, 3729-3739.
6. CHEN, W.F., and ZLOTNIK, A. (1991). IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147, 528-534.
7. CSETE, M.E., DRAZAN, K.E., BREE, M.V., and SHAKED, A. (1994). Adenovirus-mediated gene transfer in the transplant setting. Part I: Conditions for expression of transferred genes in cold preserved hepatocytes. Transplantation 57, 1502-1507.
8. DAI, Y., SCHWARZ, E.M., GU D., ZHANG, W.W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
9. DE WAAL MALEFYT, R., ABRAMS, J., BENNETT, B., FIGDOR, C.G., and DE VRIES, J.E. (1991a). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
10. DE WAAL MALEFYT, R., HAANEN, J., SPITS, H., RONCARLOL, M.G., TE VELDE, A., FIGDOR, C., JOHNSON, C., KASTELEIN, R., YSSEL, H., and DE VRIES, J.E. (1991b). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.
11. DEL, P.G., DE, C.M., ALMERIGOGNA, F., GIUDIZI, M.G., BIAGIOTTI, R., and ROMAGNANI, S. (1993). Human IL-10 is produced by both type 1 helper (TH1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353-360.
12. DEMATTEO, R.P., RAPER, S.E., AHN, M., FISHER, K.J., BURKE, C., RADU, A., WIDERA, G., CLAYTOR, B.R., BARKER, C.F., and MARKMANN, J.F. (1995). Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. Ann., Surgery 222, 229-242.
13. DEMATTEO, R.P., MARKMANN, J.F., KOZARSKY, K.F., BAKER, C.F., and RAPER, S.E. (1996). Prolongation of adenoviral transgene expression in mouse liver by T-lymphocyte subset depletion. Gene Ther. 3, 4-12.
14. DING, L., and SHEVACH, E.M. (1992). IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148, 3133-3139.
15. DING, L., LINSLEY, P.S., HUANG, L.Y., GERMAIN, R.N., and SHEVACH, E.M. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224-1234.
16. DOHERTY, P.C., ALLAN, W., and EICHELBERGER, M. (1992). Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10, 123-151.
17. DWARKI, V.J., BELLONI, P., NIJJAR, T., SMITH, J., COUTO, L., RABIER, M., CLIFT, S., BERNS, A., and COHEN, L.K. (1995). Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl. Acad. Sci. USA 92, 1023-1027.
18. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
19. ENK, A.H., ANGELONI, V.L., UDEY, M.C., and KATZ, S.I. (1993). Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151, 2390-2398.
20. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M., and O'GARRA, A. (1991). IL-10 inhibits cytokine production of activated macrophages. J. Immunol. 147, 3815-3822.
21. GO, N.F., CASTLE, B.E., BARRETT, R., KASTELEIN, R., DANG, W., MOSMANN, T.R., MOORE, K.W., and HOWARD, M. (1990). Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172, 1625-1631.
22. GORDON, E.M., and ANDERSON, W.F. (1994). Gene therapy using retroviral vectors. Curr. Opin. Biotechnol. 5, 611-616.
23. GUIDOTTI, L.G., ISHIKAWA, T., HOBBS, M.V., MATZKE, B., SCHREIBER, R., and CHISARI, F.V. (1996). Intercellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36.
24. HSU, D.H., DE WAAL MALEFYT, R., FIORENTINO, D.F., DANG, M.N., VIEIRA, P., DEVRIES, J.E., SPITS, H., MOSMANN, T.R., and MOORE, K.W. (1990). Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250, 830-832.
25. LEE, M.G., ABINA, M.A., HADDADA, H., and PERRICAUDET, M. (1995). The constitutive expression of the immunomodulatory gp19k protein in E1-, E3-adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2, 256-262.
26. MACNEIL, I.A., SUDA, T., MOORE, K.W., MOSMANN, T.R., and ZLOTNIK, A. (1990). IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145, 4167-4173.
27. McCOY, R.D., DAVIDSON, B.L., ROESSLER, B.J., HUFFNAGLE, G.B., and SIMON, R.H. (1995). Expression of human interleukin-1 receptor antagonist in mouse lung using a recombinant adenovirus: effects on vector-induced inflammation. Gene Ther. 2, 437-442.
28. MOORE, K.W., VIEIRA, P., FIORENTINO, D.F., TROUNSTINE, M.L., KHAN, T.A., and MOSMANN, T.R. (1990). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-1234.
29. QIN, L., CHAVIN, K.D., LIN, J., YAGITA, H., and BROMBERG, J.S. (1994). Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival, J. Exp. Med. 179, 341-346.
30. QIN, L., CHAVIN, K.D., DING, Y., FAVARRO, J.P., WOODWARD, J.E., LIN, J., TAHARA, H., ROBBINS, P.D., SHAKED, A., HO, D.Y., SAPOLSKY, R.M., LOTZE, M.T., and BROMBERG, J.S. (1995). Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: Immunosuppression with TGF-β1 or vIL-10. Transplantation 59, 809-816.
31. QIN, L., CHAVIN, K.D., DING, Y., TAHARA, H., FAVARO, J.P., WOODWARD, J.E., SUZUKI, T., ROBBINS, P.D., LOTZE, M.T., and BROMBERG, J.S. (1996). Retrovirus-mediated transfer of viral interleukin-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156, 2316-2323.
32. RALPH, P., NAKOINZ, I., SAMPSON, J.A., FONG, S., LOWE, D., MIN, H.Y., and LIN, L. (1992). IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol. 148, 808-814.
33. RETTINGER, S.D., KENNEDY, S.C., WU, X., SAYLORS, R.L., HAFENRICHTER, D.G., FLYE, M.W., and PONDER, K.P. (1994). Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91, 1460-1464.
34. ROUSSET, F., GARCIA, E., DEFRANCE, T., PERONNE, C., VEZZIO, N., HSU, D.H., KASTELEIN, R., MOORE, K.W., and BANCHEREAY, J. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89, 1890-1893.
35. RUFF, M.R., and GIFFORD, G.E. (1981). Rabbit tumor necrosis factor: Mechanism of action. Infect. Immun. 31, 380-386.
36. SCOTT, P. (1993). IL-12: Initiation cytokine for cell-mediated immunity. Science 260, 496-497.
37. SCHARFMANN, R., AXELROD, J.H., and VERMA, I.M. (1991). Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 89, 4626-4630.
38. TAGA, K., and TOSATO, G. (1992). IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148, 1143-1148.
39. THOMPSON, S.L., DHAR, V., BOND, M.W., MOSMANN, T.R., MOORE, K.W., and RENNICK, D.M. (1991). Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510.
40. TRAPNELL, B.C., and GORZIGLIA, M. (1994). Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5, 617-625.
41. TRIPP, C.S., WOLF, S.F., and UNANUE, E.R. (1993). Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90, 3725-3729.
42. TSUI, L.V., GUIDOTTI, L.G., ISHIKAWA, T., and CHISARI, F.V. (1995). Posttranscriptional clerance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA 92, 12398-12402.
43. WORGALL, S., WOLFF, G., FALCK-PEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
44. WOLD, W.S.M., and GOODING, L.R. (1991). Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184, 1-8.
45. VIEIRA, P., DE WAAL MALEFYT, R., DANG, M.N., JOHNSON, K.E., KASTELEIN, R., FIORENTINO, D.F., DE VRIES, J.E., RONCAROLO, M.G., MOSMANN, T.R., and MOORE, K.W. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 88, 1172-1176.
46. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
47. YANG, Y., HILDEGUND, C. J.E., and WILSON, J.M. (1994b). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
48. YANG, Y., NUNES, F.A., BERENSCI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994c). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
49. YAO, S., FARJO, A., ROESSLER, B.J., DAVIDSON, B.L., and KURACHI, K. (1996). Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver. Viral Immunol. 9, 141-153.